Cancer is a major cause of death and a prominent obstacle in improving life expectancy in every country around the world. According to GLOBOCAN, the number of new cancer cases is expected to increase from 19.2 million in 2020 to 24.5 million in 2030. In addition, mortalities from cancer are expected to increase from 9.9 million in 2020 to 12.9 million in 2030. Thus, the increasing prevalence of cancer is expected to boost the adoption of NGS in clinical settings. 

Read More: https://www.meticulousresearch.com/product/dna-sequencing-market-5992